Original Article

Effects of Vascular Endothelial Growth Factor Inhibitor–Induced Proteinuria on Treatment Course and Outcomes: Retrospective Analysis and Review of the Literature

Joshua L. Murdock, PharmD; Marissa R. Duco, PharmD; David J. Reeves, PharmD, BCOP

Effects of Levofloxacin Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia, Relapsed Acute Lymphoblastic Leukemia, or Patients Undergoing Hematopoietic Stem Cell Transplant

Livia Linden, PharmD, BCPPS; Sarah Timaeus, PharmD, BCOP; Jessica Gillon, PharmD, BCIDP; Savannah Gulley, PharmD, BCPPS

Duration of Response to PARP Inhibitors for Maintenance Treatment of Ovarian Cancer in Patients With Germline or Somatic HRD

Jordanne Adolphsen, PharmD, BCOP; Taylor Monson, PharmD, BCOP; Grace Martin, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; Richard Meier, PhD; Whitney Shae, BS, MS; Devin C. Koestler, PhD; Colleen Bohnenkamp, PharmD, BCOP

Incidence of Infusion-Related Reactions With Pertuzumab and Ado-Trastuzumab Emtansine: A Retrospective Study

Sara Moran Smith, PharmD, BCOP

Retrospective Evaluation of Initial Empiric Double Coverage with Tobramycin in Adult Patients with Febrile Neutropenia

Amber B. Clemmons, PharmD, BCOP, FHOPA; Rachel Shelley, PharmD; Vayou Chittavong, MS, PharmD; Huimin Hu, PhD; Xianyan Chen, PhD; Joshua Eudy, PharmD, BCIDP; Andrew Chao, MD; Daniel T. Anderson, PharmD, BCIDP

Stopping Oral Chemotherapy Agents With a High Bleeding Risk Before and After Minor Surgical Procedures

Dennis Marjoncu, PharmD, BCOP; Jenna Carmichael, PharmD, BCOP; Benjamin J. Andrick, PharmD, BCOP; Jacqueline Oxenberg, DO, FACS, FACOS

Incidence and Severity of Neuropathy with Concurrent Use of Voriconazole and Vincristine in Pediatric Patients with Cancer

Ashley Sabus, PharmD, BCOP; Mya Merrow, PharmD, BCOP; Ellen Burke, PharmD, BCOP; Gordon Kordas, MS; Megan Williams, PharmD; Maria Larson, PT, DPT, PCS; Kristen Eisenman, MD

Evaluation of Outcomes in Patients Who Received Bevacizumab for the Treatment of Brain Radionecrosis

Jameshia A. Below, PharmD; Alina Khan, PharmD; Amanda Brahim, PharmD, BCOP, BCPS, BCACP; Luis E. Raez, MD, FACP, FCCP; Paola Izquierdo, RN, BSN, APRN, FPBC

Safety of SC Daratumumab in the Treatment of Plasma-Cell Disorders: A Single-Center Experience

Jung Kye, PharmD, BCOP; Samit Patel, PharmD, BCOP; Maggie Seyer, PharmD, BCPS; Eun-Jeong Kim, PharmD, MS, BCOP; Rhonda Hewitt, MSN, ANP, AOCNP; Michaela Liedtke, MD; David Iberri, MD

Comparing the Efficacy and Safety of Reference Drug Filgrastim and Biosimilar Filgrastim-sndz in Pediatric Patients Used for Post–Hematopoietic Stem-Cell Transplant Engraftment or Chemotherapy-Induced Febrile Neutropenia Prophylaxis

Cassandra Rush, PharmD; Ashley Sabus, PharmD, BCOP; Obehi Enabulele, PharmD, MBA, MS; Abby Kim, BA, PharmD, BCOP

Page 1 of 12
Results 1 - 10 of 119

Subscribe Today!

I'd like to receive:

Original Article